138 related articles for article (PubMed ID: 38073018)
21. Kaposiform hemangioendothelioma in children: a benign vascular tumor with multiple treatment options.
Schmid I; Klenk AK; Sparber-Sauer M; Koscielniak E; Maxwell R; Häberle B
World J Pediatr; 2018 Aug; 14(4):322-329. PubMed ID: 30054848
[TBL] [Abstract][Full Text] [Related]
22. Clinical Outcomes for Systemic Corticosteroids Versus Vincristine in Treating Kaposiform Hemangioendothelioma and Tufted Angioma.
Liu X; Li J; Qu X; Yan W; Zhang L; Zhang S; Yang C; Zheng J
Medicine (Baltimore); 2016 May; 95(20):e3431. PubMed ID: 27196448
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Corticosteroid and Vincristine in Treating Kaposiform Hemangioendothelioma and Tufted Angioma: A Systematic Review and Meta-Analysis.
Yao W; Li K; Wang Z; Pei J; Liu X; Zheng S; Dong K
Eur J Pediatr Surg; 2019 Oct; 29(5):401-407. PubMed ID: 30372769
[TBL] [Abstract][Full Text] [Related]
24. Retroperitoneal kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon and obstructive jaundice: A retrospective series of 3 patients treated with sirolimus.
Yao W; Li K; Wang Z; Dong K; Zheng S
Pediatr Dermatol; 2020 Jul; 37(4):677-680. PubMed ID: 32212177
[TBL] [Abstract][Full Text] [Related]
25. [Refractory kaposiforme hemangioendothelioma in the pediatric population: case report and literature review.].
Gómez-Villegas CP; Pérez-Téllez C; Ochoa-Gaviria J; Builes N
Bol Med Hosp Infant Mex; 2021; 78(4):376-384. PubMed ID: 34351887
[TBL] [Abstract][Full Text] [Related]
26. Management of Refractory Pediatric Kaposiform Hemangioendothelioma With Sirolimus and Aspirin.
MacFarland SP; Sullivan LM; States LJ; Bailey LC; Balamuth NJ; Womer RB; Olson TS
J Pediatr Hematol Oncol; 2018 May; 40(4):e239-e242. PubMed ID: 29240034
[TBL] [Abstract][Full Text] [Related]
27. Role of Sirolimus in Advanced Kaposiform Hemangioendothelioma.
Oza VS; Mamlouk MD; Hess CP; Mathes EF; Frieden IJ
Pediatr Dermatol; 2016; 33(2):e88-92. PubMed ID: 26864138
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical Analysis of mTOR Pathway-Related Proteins in Kaposiform Hemangioendothelioma.
Wang Z; Zheng C; Sun H; Yao W; Li K; Ma Y; Zheng S
Dermatology; 2020; 236(3):262-270. PubMed ID: 31896113
[TBL] [Abstract][Full Text] [Related]
29. Kaposiform hemangioendothelioma and tufted angioma - (epi)genetic analysis including genome-wide methylation profiling.
Ten Broek RW; Koelsche C; Eijkelenboom A; Mentzel T; Creytens D; Vokuhl C; van Gorp JM; Versleijen-Jonkers YM; van der Vleuten CJ; Kemmeren P; van de Geer E; von Deimling A; Flucke U
Ann Diagn Pathol; 2020 Feb; 44():151434. PubMed ID: 31887709
[TBL] [Abstract][Full Text] [Related]
30. Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants.
Wang Y; Kong L; Sun B; Cui J; Shen W
J Craniofac Surg; 2020 Jun; 31(4):1074-1077. PubMed ID: 32176003
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of kaposiform hemangioendothelioma and tufted angioma with vincristine.
Fahrtash F; McCahon E; Arbuckle S
J Pediatr Hematol Oncol; 2010 Aug; 32(6):506-10. PubMed ID: 20523249
[TBL] [Abstract][Full Text] [Related]
32. Kaposiform haemangioendothelioma: a review with emphasis on histological differential diagnosis.
Putra J; Gupta A
Pathology; 2017 Jun; 49(4):356-362. PubMed ID: 28438388
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological features of Kaposiform hemangioendothelioma.
Liu Q; Jiang L; Wu D; Kan Y; Fu F; Zhang D; Gong Y; Wang Y; Dong C; Kong L
Int J Clin Exp Pathol; 2015; 8(10):13711-8. PubMed ID: 26722599
[TBL] [Abstract][Full Text] [Related]
34. Sirolimus Treatment of an Infant With Intrathoracic Kaposiform Hemangioendothelioma Complicated by Life-threatening Pleural and Pericardial Effusions.
Duan L; Renzi S; Weidman D; Waespe N; Chami R; Manson D; Cada M; Carcao M
J Pediatr Hematol Oncol; 2020 Jan; 42(1):74-78. PubMed ID: 30044355
[TBL] [Abstract][Full Text] [Related]
35. Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial.
Ji Y; Chen S; Zhou J; Yang K; Zhang X; Xiang B; Qiu T; Gong X; Zhang Z; Lan Y; Hu F; Kong F; Qiu Q; Zhang Y
Blood; 2022 Mar; 139(11):1619-1630. PubMed ID: 35030255
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcomes of sirolimus treatment for kaposiform hemangioendothelioma: Continuing successes and ongoing challenges.
Zhou J; Li Y; Qiu T; Gong X; Yang K; Zhang X; Zhang Z; Lan Y; Hu F; Peng Q; Zhang Y; Kong F; Chen S; Ji Y
Int J Cancer; 2023 Aug; 153(3):600-608. PubMed ID: 36916140
[TBL] [Abstract][Full Text] [Related]
37. Kaposiform haemangioendothelioma in an adult: lack of response to topical sirolimus and response to radiotherapy.
Der Sarkissian SA; Wong XL; Kossard S; Hong A; Sebaratnam DF
Clin Exp Dermatol; 2022 Jan; 47(1):192-193. PubMed ID: 34480811
[TBL] [Abstract][Full Text] [Related]
38. Kaposiform hemangioendothelioma: current knowledge and future perspectives.
Ji Y; Chen S; Yang K; Xia C; Li L
Orphanet J Rare Dis; 2020 Feb; 15(1):39. PubMed ID: 32014025
[TBL] [Abstract][Full Text] [Related]
39. Interferon-alpha therapy for refractory kaposiform hemangioendothelioma: a single-center experience.
Wu HW; Wang X; Zhang L; Zhao HG; Wang YA; Su LX; Fan XD; Zheng JW
Sci Rep; 2016 Oct; 6():36261. PubMed ID: 27796340
[TBL] [Abstract][Full Text] [Related]
40. Mediastinal kaposiform hemangioendothelioma and Kasabach-Merritt phenomenon in a patient with no skin changes and a normal chest CT.
Wallenstein MB; Hole MK; McCarthy C; Fijalkowski N; Jeng M; Wong WB
Pediatr Hematol Oncol; 2014 Sep; 31(6):563-7. PubMed ID: 24047193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]